药品注册申请号:011210
申请类型:NDA (新药申请)
申请人:PFIZER
申请人全名:PFIZER INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 TESSALON BENZONATATE CAPSULE;ORAL 100MG Yes No AA 1958/02/10 Approved Prior to Jan 1, 1982 Prescription
003 TESSALON BENZONATATE CAPSULE;ORAL 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No None 1999/06/25 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2011/01/20 SUPPL-53(补充) Approval Labeling UNKNOWN
2002/07/23 SUPPL-41(补充) Approval Manufacturing (CMC) STANDARD
2000/11/01 SUPPL-40(补充) Approval Manufacturing (CMC) STANDARD
2000/06/30 SUPPL-39(补充) Approval Manufacturing (CMC) STANDARD
1999/06/25 SUPPL-35(补充) Approval Manufacturing (CMC) STANDARD
1999/06/08 SUPPL-37(补充) Approval Manufacturing (CMC) STANDARD
1993/12/01 SUPPL-32(补充) Approval Manufacturing (CMC) STANDARD
1992/09/04 SUPPL-31(补充) Approval Labeling
1986/10/08 SUPPL-30(补充) Approval Labeling
1985/11/29 SUPPL-29(补充) Approval Labeling
1985/11/29 SUPPL-25(补充) Approval Labeling
1985/11/05 SUPPL-27(补充) Approval Manufacturing (CMC) STANDARD
1985/06/13 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
1981/07/15 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
1980/07/03 SUPPL-21(补充) Approval Manufacturing (CMC) STANDARD
1979/08/28 SUPPL-20(补充) Approval Manufacturing (CMC) STANDARD
1979/07/06 SUPPL-19(补充) Approval Manufacturing (CMC) STANDARD
1978/10/24 SUPPL-14(补充) Approval Manufacturing (CMC) STANDARD
1978/09/29 SUPPL-18(补充) Approval Labeling
1978/09/29 SUPPL-15(补充) Approval Manufacturing (CMC) STANDARD
1975/03/31 SUPPL-13(补充) Approval Manufacturing (CMC) STANDARD
1974/12/30 SUPPL-11(补充) Approval Supplement STANDARD
1972/04/12 SUPPL-2(补充) Approval Labeling
1958/02/10 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:BENZONATATE 剂型/给药途径:CAPSULE;ORAL 规格:100MG 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
011210 001 NDA TESSALON BENZONATATE CAPSULE;ORAL 100MG Prescription Yes No AA Approved Prior to Jan 1, 1982 PFIZER
081297 001 ANDA BENZONATATE BENZONATATE CAPSULE;ORAL 100MG Prescription No No AA 1993/01/29 BIONPHARMA
040627 001 ANDA BENZONATATE BENZONATATE CAPSULE;ORAL 100MG Discontinued No No AA 2007/03/30 THEPHARMANETWORK LLC
040597 001 ANDA BENZONATATE BENZONATATE CAPSULE;ORAL 100MG Prescription No No AA 2007/06/08 ZYDUS PHARMS USA
040682 001 ANDA BENZONATATE BENZONATATE CAPSULE;ORAL 100MG Prescription No No AA 2007/07/30 HERITAGE PHARMS LABS
091310 001 ANDA BENZONATATE BENZONATATE CAPSULE;ORAL 100MG Prescription No No AA 2015/01/16 ACELLA
091133 001 ANDA BENZONATATE BENZONATATE CAPSULE;ORAL 100MG Prescription No No AA 2015/07/30 STRIDES PHARMA
202765 002 ANDA BENZONATATE BENZONATATE CAPSULE;ORAL 100MG Prescription No No AA 2017/08/25 CSPC-NBP PHARM
206948 001 ANDA BENZONATATE BENZONATATE CAPSULE;ORAL 100MG Prescription No Yes AA 2018/12/19 PURACAP PHARM LLC
211518 001 ANDA BENZONATATE BENZONATATE CAPSULE;ORAL 100MG Prescription No No AA 2019/02/22 ASCENT PHARMS INC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database